Cargando…
Liver Cancer: Therapeutic Challenges and the Importance of Experimental Models
Liver cancer is one of the main causes of death related to cancer worldwide; its etiology is related with infections by C or B hepatitis virus, alcohol consumption, smoking, obesity, nonalcoholic fatty liver disease, diabetes, and iron overload, among other causes. Several kinds of primary liver can...
Autores principales: | Galicia-Moreno, Marina, Silva-Gomez, Jorge A, Lucano-Landeros, Silvia, Santos, Arturo, Monroy-Ramirez, Hugo C, Armendariz-Borunda, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937489/ https://www.ncbi.nlm.nih.gov/pubmed/33728291 http://dx.doi.org/10.1155/2021/8837811 |
Ejemplares similares
-
Roles of Nrf2 in Liver Diseases: Molecular, Pharmacological, and Epigenetic Aspects
por: Galicia-Moreno, Marina, et al.
Publicado: (2020) -
Hepatocarcinogenesis Prevention by Pirfenidone Is PPARγ Mediated and Involves Modification of Nuclear NF-kB p65/p50 Ratio
por: Silva-Gomez, Jorge Antonio, et al.
Publicado: (2021) -
Epidemiologic, Genetic, Pathogenic, Metabolic, Epigenetic Aspects Involved in NASH-HCC: Current Therapeutic Strategies
por: Gutiérrez-Cuevas, Jorge, et al.
Publicado: (2022) -
PPARs as Metabolic Sensors and Therapeutic Targets in Liver Diseases
por: Monroy-Ramirez, Hugo Christian, et al.
Publicado: (2021) -
Pirfenidone Protects from UVB-Induced Photodamage in Hairless Mice
por: Martinez-Alvarado, Yocasta, et al.
Publicado: (2023)